Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
23.52
+0.52 (2.26%)
At close: May 20, 2025, 4:00 PM
23.53
+0.01 (0.04%)
After-hours: May 20, 2025, 7:59 PM EDT
Pfizer Analyst Ratings
Total Analysts
14
Consensus Rating
Hold
Price Target
$29.92
Upside
+27.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | +6.29% | Apr 30, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $24 | Hold | Initiates | $24 | +2.04% | Apr 22, 2025 |
| UBS | UBS | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +2.04% | Apr 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $32 → $25 | Strong Buy → Hold | Downgrades | $32 → $25 | +6.29% | Apr 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +40.31% | Feb 10, 2025 |
| UBS | UBS | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +19.05% | Feb 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $30 → $29 | Hold | Maintains | $30 → $29 | +23.30% | Jan 28, 2025 |
| UBS | UBS | Hold Maintains $31 → $29 | Hold | Maintains | $31 → $29 | +23.30% | Jan 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $32 | Strong Buy | Maintains | $36 → $32 | +36.05% | Dec 18, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +40.31% | Dec 11, 2024 |
| B of A Securities | B of A Securities | Hold Initiates $29 | Hold | Initiates | $29 | +23.30% | Dec 10, 2024 |
| Wolfe Research | Wolfe Research | Sell Initiates $25 | Sell | Initiates | $25 | +6.29% | Nov 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $30 → $31 | Hold | Maintains | $30 → $31 | +31.80% | Oct 30, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +91.33% | Oct 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.